// App-Quantinova.ai

: EVALUATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY AS PROGNOSTIC MARKERS IN A PEDIATRIC PATIENT COHORT WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Monika Haubitz

Principal Investigators

  • Axel Karow

  • Ingrid Helsen

  • Daniela Steiner

  • Roland A. Ammann

  • Mutlu Kartal-Kaess

  • Jochen K. Rssler

  • Elisabeth Oppliger Leibundgut

  • Gabriela M. Baerlocher

Medical Centers

  • Hematology Adults, Laboratory for Hematopoiesis and Molecular Genetics, Department for BioMedical Research (DBMR),University of Bern,Bern,Switzerland

  • Division of Pediatric Hematology/Oncology, Department of Pediatrics,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland

  • Hematology Adults, Laboratory for Hematopoiesis and Molecular Genetics, Department for BioMedical Research (DBMR),University of Bern,Bern,Switzerland;Department of Hematology and Central Hematology Laboratory,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland

  • Department for BioMedical Research,University of Bern,Bern,Switzerland;Department of Hematology and Central Hematology Laboratory,Inselspital, Bern University Hospital, University of Bern,Bern,Switzerland

Locations

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved